
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
https://www.pharmacytimes.org/on-demand/ajmc-payer-forum-reducing-influenza-duration-related-complications-and-healthcare-costs-with-novel-antivirals





